Convertible Preferred Stock and Stockholders’ Equity - Schedule of Outstanding Warrants (Details) - Warrants [Member] - $ / shares |
3 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Mar. 31, 2025 |
|
| Schedule of Outstanding Warrants [Line Items] | ||
| Number of Shares, Outstanding at ending | 1,175,333 | 1,175,333 |
| Weighted Average Grant Date Fair Value, Outstanding at ending | $ 6.72 | $ 6.72 |
| Weighted Average Remaining Contractual Life, Outstanding at ending | 2 years 11 months 1 day | 2 years 8 months 1 day |
| Number of Shares, Warrants vested and exercisable | 583,475 | |
| Weighted Average Grant Date Fair Value, Warrants vested and exercisable | $ 9.1 | |
| Weighted Average Remaining Contractual Life, Warrants vested and exercisable | 2 years 3 months 29 days | |
| Number of Shares, Granted | ||
| Weighted Average Grant Date Fair Value, Granted | ||
| Number of Shares, Exercised | ||
| Weighted Average Grant Date Fair Value, Exercised | ||
| Number of Shares, Cancelled | ||
| Weighted Average Grant Date Fair Value, Cancelled |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that exercised during the reporting period. No definition available.
|
| X | ||||||||||
- Definition The weighted average exercise price of warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price of warrants vested and exercisable. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are warrants vested and exercisable as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual life of warrants vested and exercisable. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|